🇺🇸 FDA

Company profile · Sponsor

PAION

PAION Pharma GmbH

E0B0F13 · EMA pharma EU
Pipeline
1
Drugs
0
Patents
0

Quick answer

PAION (E0B0F13) is a pharma company. headquartered in EU. listed on EMA. NovaPharmaNews links 1 pipeline program, 0 drugs, and 0 patents to this profile..

Company facts

Ticker E0B0F13
Exchange EMA
Company type pharma
Headquarters EU

Pipeline (1)

Search pipeline →

  1. Giapreza 2.5 mg/ml concentrate for solution for infusion, SODIUM CHLORIDE SOLUTION 0.9%

    PAION

    refractory hypotension in distributive shock

    phase 3 small molecule active

    1 trial

Frequently asked questions

What is PAION?

PAION (E0B0F13) is a pharma company. headquartered in EU. listed on EMA. NovaPharmaNews links 1 pipeline program, 0 drugs, and 0 patents to this profile..

What pipeline programs does PAION sponsor?

We track 1 ClinicalTrials.gov-linked program for PAION, including Giapreza 2.5 mg/ml concentrate for solution for infusion, SODIUM CHLORIDE SOLUTION 0.9%. Open each program for phase, modality, NCT IDs, and indication details.

Where does PAION company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.